The recent Business of Cannabis Summit in New York City brought together industry professionals at the trendy Wythe Hotel in Williamsburg, Brooklyn, for a day focused on tackling the cannabis industry’s toughest challenges: price compression, retail survival, and the slow but steady shift from legacy to [...]
Small doses of the psychedelic led to a nearly 60% reduction in depression symptoms and could also help with other factors, such as anxiety and quality of life. This story first appeared on leafie, view here Author: Kevin Dinneen
With shifting perceptions, economic incentives, and the evolution of international regulatory frameworks, more countries around the world are starting to embrace legal cannabis for its medical and recreational uses. One of the hotspots of legalization remains the European Union, where countries like Malta and Luxembourg have [...]
Seven years after medical cannabis was legalised in the UK, new data from Releaf sheds light on how the treatment is changing patients’ lives, but also where progress is still needed. This month, Releaf Cannabis Clinic published one of the most comprehensive surveys of UK medical [...]
Most cannabis operators I meet are juggling a lot more than they expected. One day they’re handling payroll, the next they’re sorting out compliance, and somehow still trying to grow the business. HR usually gets squeezed somewhere in between. It’s not that owners don’t care about [...]
There was no more fitting venue for a cannabis industry gathering than the Museum of the American Revolution in Philadelphia. The historic setting served as the backdrop for the Accelerate Cannabis Summit, a groundbreaking event that brought together cannabis leaders, entrepreneurs, and government officials from across [...]
Medical cannabis patients made history with a patient-led educational event about cannabis-based medicines, held at the Charterhouse in London. The international patient-led organisation We, The Patients, brought its educational event series to London for the first time on Friday 7 November, in partnership with PatientsCann UK, [...]
A panel discussion at the recent Business of Cannabis event in NYC analyzed the serious issues still facing the industry rollout in New York. What has been touted as a social equity-first initiative has been riddled with significant challenges and lawsuits. To date, the Office of [...]
Seven years after the legalisation of medical cannabis, thousands of patients remain without access as institutional support lags behind demand. This story first appeared on leafie, view here Author: Liam O'Dowd
Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers of pharmaceutical-grade medicinal cannabis. Under this agreement, Curaleaf Laboratories will manufacture and distribute ANTG’s range of [...]
For the first time, cannabis brands can claim airtime right alongside household names like Nike and Home Depot. Streaming platforms are serving Fortune 500 advertisers every hour, and now compliant cannabis companies are joining the lineup. This article breaks down how Connected TV (CTV) unlocks new [...]
A federally funded study has found that cannabis use among Canadian adolescents decreased following the country's 2018 legalisation, dispelling concerns that legal adult access leads to increased youth consumption. This story first appeared on leafie, view here Author: Liam O'Dowd
The highlight of the Business of Cannabis event, held at the Wythe Hotel in Williamsburg, a hip neighborhood in Brooklyn, New York, was the keynote speaker. Ethan Nadelmann, founder of the Drug Policy Alliance, has since retired from his position but continues to mentor and serve [...]
This has been a whirlwind year in Washington, D.C., with the inauguration of President Donald Trump and the swearing in of a new Republican majority in the U.S. Senate. The “Republican trifecta” of the House, Senate, and administration has led to stalled progress with cannabis legalization, [...]
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it [...]
A large UK study suggests that people who use cannabis to self-medicate for pain or anxiety may be more likely to experience paranoia, prompting calls for improved patient monitoring in private prescribing. Researchers from King’s College London recently published the first findings from the Cannabis & [...]
At the recent Business of Cannabis event in New York, Robert Sciarrone, Chief Revenue Officer at Curaleaf, shared an MSO’s insider view on why he believes New York is poised to become the best cannabis market on the planet. Sciarrone began by reflecting on his early [...]
A report published by the All-Party Parliamentary Group on Medical Cannabis under Prescription highlights urgent need for reform to unlock the sector's potential and improve patient access seven years after legalisation. This story first appeared on leafie, view here Author: Kevin Dinneen
From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we still need more research? In the face of long NHS waiting lists and a lack of options in mainstream healthcare, [...]
A long-term study of over 1,500 young people revealed that teenagers who start using cannabis before age 15 are at significantly higher risk of developing both mental and physical health problems requiring medical treatment in early adulthood. This story first appeared on leafie, view here Author: [...]
Families have marked the seventh anniversary of the legalisation of medical cannabis in the UK with further calls for urgent government action on NHS access. Dozens of families attended Westminster on Tuesday (4 November) to meet with cross-party MPs and demand immediate action to address the [...]
Cannabis products are increasingly held to the same standards as food and pharmaceuticals, and that means verifying how their potency and composition change over time. Cannabis stability testing provides the data needed to establish reliable shelf life, confirm product consistency, and guide formulation optimization for improved [...]
A Thai study of 491 patients with aggressive bile duct cancer found those receiving medicinal cannabis alongside palliative care survived longer than those receiving standard care alone. This story first appeared on leafie, view here Author: Kevin Dinneen
As cannabis production scales and testing standards tighten, cultivators face increasing pressure to ensure their products are free from harmful microbes without compromising quality. Decontamination, the process of removing or killing microorganisms, has become a common step in post-harvest processing. Traditional methods come with trade-offs that [...]
The endocannabinoid system (ECS) helps regulate vital bodily functions from mood and pain to immune response, yet it remains one of medicine’s best-kept secrets. We unpack the science behind the ECS and its significance in a range of chronic conditions. The endocannabinoid system (ECS) plays a [...]
Zurich’s flagship adult-use cannabis trial, Züri Can, could now run until 2028 after city officials applied this week to extend the project by two years, citing strong early results in reducing illicit sales and promoting safer consumption. The move comes as the Swiss Federal Government continues [...]
The Lebanese government has established a regulatory body to oversee legal cannabis production for pharmaceutical purposes, in the hope of transforming the country's struggling economy whilst ending decades of illegal cultivation. This story first appeared on leafie, view here Author: Liam O'Dowd
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is a Continuing Professional Development (CPD)-accredited event, meaning attendees can earn professional development credits as a result of their participation. The [...]
MariMed, one of the nation’s leading multi-state cannabis operators, began in the medical cannabis market and expanded into adult-use as states legalized. Through this growth, the company has remained true to its “medical-first” approach, ensuring that product quality, safety, and consistency remain at the core of [...]
A large study of over 66,000 patients diagnosed with alcohol use disorder found that heavy cannabis users are up to 40% less likely to develop severe liver complications. This story first appeared on leafie, view here Author: Kevin Dinneen
For decades, cannabis has lived in a research dead zone. Federal prohibition has blocked meaningful grants, limited clinical trials, and left millions of people with cancer relying on anecdotal evidence for treatment rather than data. As founders of E.R.I.C. Cancer Playbook, we refused to accept that. [...]
Researchers have created a synthetic compound from caraway seeds that shows greater effectiveness than current childhood epilepsy medications, offering hope for safer treatments without cannabis-related regulatory barriers. This story first appeared on leafie, view here Author: Kevin Dinneen
Jason Ambrosino, a disabled Army veteran and founder of Veterans Holdings, entered the New York market in 2019 under the state’s hemp program with the goal of cultivating and manufacturing cannabis. But despite holding a 5,000-square-foot indoor cultivation license, he decided not to build out his [...]
More than 2,300 people have been able to purchase cannabis legally through the city's pilot programme, with officials citing it's success in undermining the black market. This story first appeared on leafie, view here Author: Liam O'Dowd
New research reveals that people who use both cannabis and tobacco have significantly different brain chemistry compared to cannabis-only users, potentially explaining higher rates of anxiety, depression, and addiction in co-users. This story first appeared on leafie, view here Author: Kevin Dinneen
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it [...]
Almost seven years since medical cannabis was legalised in the UK on 1st November 2018, less than 1% of the UK’s approximate 100,000 doctors on the General Medical Council (GMC) Specialist Register have the training required to prescribe medical cannabis. While the UK’s medical cannabis market [...]
A growing number of patients are now prescribed medical cannabis for common mental health issues and neurodiverse conditions, such as autism and ADHD. Ahead of Cannabis Health Symposium next month, we examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry. Many [...]
A new health-tech company, EM2P2, has launched CannaLnx, a HIPAA-compliant platform it claims will make medical cannabis reimbursable under traditional health insurance plans for the first time in the U.S. The system, announced in partnership with the American Council of Cannabis Medicine (ACCM), is described as [...]
Curaleaf Laboratories has been confirmed as headline sponsor of the inaugural Cannabis Health Symposium, taking place on 25 November 2025 at Conway Hall, London. The event, delivered in partnership with the Medical Cannabis Clinicians Society (MCCS), will focus on strengthening clinical understanding and confidence in prescribing [...]
The Advisory Council on the Misuse of Drugs (ACMD) has closed its latest call for evidence into the impact of medical cannabis legalisation, in what will mark the most comprehensive review of the UK’s cannabis-based products for medicinal use (CBPM) framework since it was introduced in [...]
In cannabis, it sometimes feels like every financial conversation ends the same way: “If not for 280E, we’d be thriving.” That line gets repeated in boardrooms and investor decks across the country, and for good reason. Section 280E has choked margins, slowed growth, and kept great [...]
A comprehensive survey of over 113,000 teenagers across Europe has revealed declining alcohol and drug use but rising concerns over e-cigarettes, social media addiction and online gambling, particularly among girls. This story first appeared on leafie, view here Author: Liam O'Dowd
Most cannabis dispensaries are small businesses. That often means they operate on tight margins and require employees to take on roles outside their typical job descriptions. It’s common for owners or general managers to handle HR and payroll functions themselves. What begins as an understandable cost-saving measure, however, [...]
Research involving nearly 140,000 participants found that frequent cannabis users had significantly reduced odds of developing common sinus conditions when compared to non-users. This story first appeared on leafie, view here Author: Kevin Dinneen
Multiple scientific studies and lab results have provided compelling evidence that terpenes and volatile metabolites in cannabis rapidly degrade when exposed to light, oxygen, heat, and time, and therefore, reduce the entourage effect that depends on a specific balance of cannabinoids and terpenes. Because of this, [...]
We, The Patients have announced they will host a free medical cannabis education event in London in November to bridge the understanding between patients and healthcare professionals. This story first appeared on leafie, view here Author: Liam O'Dowd
How one oncologist is helping redefine patient care and the future of integrated healthcare. Medical cannabis is starting to have a very different kind of conversation in the UK. From mainstream voices like Rory Cellan-Jones exploring patient experiences on his Movers & Shakers podcast, to growing [...]
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After seven years of endeavour, and an investment of over $250m, its VER-01 chronic pain-relief drug has passed a Phase 3 trial in its home market. As [...]
As the prevalence of dementia and other neurodegenerative conditions continues to rise globally, there is growing interest in the role of cannabis-based medicines in symptom management. A small number of studies, combined with real-world clinical experience is beginning to provide important insights into the potential of [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
